HomeSucralfate

Sucralfate

Also known as: Sucralfate

Aluminum Complex

Route: Oral

Check Sucralfate Interactions →
24 interactions on record

Sucralfate has 24 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Ciprofloxacin, Cimetidine, Delafloxacin Meglumine. Patients taking Sucralfate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
24
Major
1
Moderate
23

Major (1)

  • Sucralfate + CiprofloxacinConcurrent administration may substantially decrease ciprofloxacin absorption, resulting in serum and urine levels consi

Moderate (23)

  • Sucralfate + CimetidineSucralfate reduces the bioavailability of cimetidine. Dosing cimetidine 2 hours before sucralfate eliminates the interac
  • Sucralfate + Delafloxacin MeglumineSucralfate forms chelates with delafloxacin, substantially interfering with absorption and resulting in considerably low
  • Sucralfate + DigoxinSucralfate reduces the bioavailability of digoxin. Dosing digoxin 2 hours before sucralfate eliminates the interaction.
  • Sucralfate + FurosemideSimultaneous administration of sucralfate and furosemide may reduce natriuretic and antihypertensive effects. Separate i
  • Sucralfate + Furosemide, Benzalkonium ChlorideSimultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects
  • Sucralfate + KetoconazoleSucralfate reduces the bioavailability of ketoconazole. Monitor absorption when used concomitantly.
  • Sucralfate + L-ThyroxineSucralfate reduces the bioavailability of l-thyroxine. Separate dosing administration is recommended.
  • Sucralfate + LevofloxacinAbsorption of levofloxacin is decreased when tablets are taken within 2 hours, resulting in considerably lower systemic
  • Sucralfate + Levothyroxine SodiumMay cause hypochlorhydria and affect intragastric pH, reducing levothyroxine absorption. Monitor patients appropriately.
  • Sucralfate + Macrolide AntibioticsSucralfate reduces the bioavailability of fluoroquinolone antibiotics. Dosing 2 hours before sucralfate eliminates the i
  • Sucralfate + MoxifloxacinForms chelates with moxifloxacin, substantially decreasing absorption. Take moxifloxacin at least 4 hours before or 8 ho
  • Sucralfate + Moxifloxacin HydrochlorideDecreased moxifloxacin absorption due to chelate formation. Take moxifloxacin at least 4 hours before or 8 hours after s
  • Sucralfate + Moxifloxacin Hydrochloride Tablets, 400 MgSucralfate forms chelates with moxifloxacin, substantially interfering with absorption. Take moxifloxacin at least 4 hou
  • Sucralfate + NaproxenConcomitant administration can delay the absorption of naproxen.
  • Sucralfate + NorfloxacinSucralfate reduces the bioavailability of norfloxacin. Dosing norfloxacin 2 hours before sucralfate eliminates the inter
  • Sucralfate + OfloxacinSucralfate reduces the bioavailability of ofloxacin. Dosing ofloxacin 2 hours before sucralfate eliminates the interacti
  • Sucralfate + PhenytoinSucralfate reduces the bioavailability of phenytoin. Separate dosing administration is recommended.
  • Sucralfate + Phenytoin SodiumMay decrease phenytoin serum levels; monitoring of phenytoin levels recommended.
  • Sucralfate + QuinidineSucralfate reduces the bioavailability of quinidine. Separate dosing administration is recommended.
  • Sucralfate + RanitidineSucralfate reduces the bioavailability of ranitidine. Dosing ranitidine 2 hours before sucralfate eliminates the interac
  • Sucralfate + TetracyclineSucralfate reduces the bioavailability of tetracycline. Separate dosing administration is recommended.
  • Sucralfate + TheophyllineSucralfate reduces the bioavailability of theophylline. Separate dosing administration is recommended.
  • Sucralfate + WarfarinSubtherapeutic prothrombin times reported with concomitant warfarin and sucralfate; however, clinical studies showed no

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.